ABSTRACT Staphylococcus aureus is a commensal bacterium of humans that can cause a spectrum of diseases. An isolate's capacity to cause disease is partially attributed to the acquisition of novel mobile genetic elements. This report provides the draft genome sequence of one methicillin-susceptible and seven methicillin-resistant clinical human S. aureus isolates.
S
taphylococcus aureus is a component of the microbiota of normal humans but is also able to cause a wide range of diseases, from mild skin and soft tissue infections to systemic or toxin-mediated disease. In 1961, the first isolates of methicillin-resistant S. aureus (MRSA) were reported in the hospital setting (1). More recently, MRSA isolates have been found outside the hospital setting, and isolates are now classified based on epidemiological characteristics into the following categories: hospital acquired (HA-MRSA), community acquired (CA-MRSA), and livestock associated (LA-MRSA). Multilocus sequence typing is used to define lineages of S. aureus into sequence types (ST). Isolates within a given ST possess attributes specific to that group that cause them to behave similarly. For example, MRSA ST5, as well as methicillin-sensitive S. aureus (MSSA), isolates compose a lineage that is widespread and highly pathogenic (2). These isolates are readily able to acquire virulence genes and antimicrobial resistance genes by horizontal gene transfer (2), which allows them to cause more severe disease and treatment failures.
In this report, we present draft genome sequences for one MSSA ST5 isolate (BD14054) and seven MRSA ST5 isolates (BD13502, BD13582, BD13938, BD14262, BD14436, BD14655, and BD14811). The isolates were obtained from the University of California, San Francisco, where they were isolated from patients with S. aureus-related disease. Full patient histories were not available, so we were unable to determine whether isolates were HA-MRSA or CA-MRSA; however, the urban location of the hospital ruled out LA-MRSA. Isolates were grown in Trypticase soy broth (BD Biosciences, Sparks, MD, USA), and total genomic DNA was isolated with the High Pure template preparation kit (Roche Applied Science, Indianapolis, IN, USA).
The draft genome sequences were generated with the Illumina MiSeq platform. The Nextera XT DNA sample preparation and index kit (Illumina, San Diego, CA, USA) was used to generate indexed libraries that were pooled and sequenced with the MiSeq V2 500-cycle reagent kit (Illumina). This generated 2 ϫ 250-bp paired-end reads that were assembled into draft genomes using MIRA version 4.0.2 (http://mira -assembler.sourceforge.net/docs/DefinitiveGuideToMIRA.html). Average coverage for each isolate was 74.95ϫ (BD13502), 58.07ϫ (BD13582), 47.09ϫ (BD13938), 42.02ϫ
